Literature DB >> 27046272

An approach for estimating item sensitivity to within-person change over time: An illustration using the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog).

N Maritza Dowling1, Daniel M Bolt2, Sien Deng2.   

Abstract

When assessments are primarily used to measure change over time, it is important to evaluate items according to their sensitivity to change, specifically. Items that demonstrate good sensitivity to between-person differences at baseline may not show good sensitivity to change over time, and vice versa. In this study, we applied a longitudinal factor model of change to a widely used cognitive test designed to assess global cognitive status in dementia, and contrasted the relative sensitivity of items to change. Statistically nested models were estimated introducing distinct latent factors related to initial status differences between test-takers and within-person latent change across successive time points of measurement. Models were estimated using all available longitudinal item-level data from the Alzheimer's Disease Assessment Scale-Cognitive subscale, including participants representing the full-spectrum of disease status who were enrolled in the multisite Alzheimer's Disease Neuroimaging Initiative. Five of the 13 Alzheimer's Disease Assessment Scale-Cognitive items demonstrated noticeably higher loadings with respect to sensitivity to change. Attending to performance change on only these 5 items yielded a clearer picture of cognitive decline more consistent with theoretical expectations in comparison to the full 13-item scale. Items that show good psychometric properties in cross-sectional studies are not necessarily the best items at measuring change over time, such as cognitive decline. Applications of the methodological approach described and illustrated in this study can advance our understanding regarding the types of items that best detect fine-grained early pathological changes in cognition. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2016        PMID: 27046272      PMCID: PMC4959988          DOI: 10.1037/pas0000285

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  39 in total

Review 1.  Cognitive screening and neuropsychological assessment in early Alzheimer's disease.

Authors:  D P Salmon; K L Lange
Journal:  Clin Geriatr Med       Date:  2001-05       Impact factor: 3.076

2.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  K A Welsh; N Butters; J P Hughes; R C Mohs; A Heyman
Journal:  Arch Neurol       Date:  1992-05

3.  Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease.

Authors:  Daniel A Llano; Genevieve Laforet; Viswanath Devanarayan
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

4.  A phase II trial of huperzine A in mild to moderate Alzheimer disease.

Authors:  M S Rafii; S Walsh; J T Little; K Behan; B Reynolds; C Ward; S Jin; R Thomas; P S Aisen
Journal:  Neurology       Date:  2011-04-19       Impact factor: 9.910

5.  Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease.

Authors:  T Bussière; G Gold; E Kövari; P Giannakopoulos; C Bouras; D P Perl; J H Morrison; P R Hof
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

6.  High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Authors:  Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron F Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2008-10-15       Impact factor: 56.272

7.  Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.

Authors:  Hélène Amieva; Mélanie Le Goff; Xavier Millet; Jean Marc Orgogozo; Karine Pérès; Pascale Barberger-Gateau; Hélène Jacqmin-Gadda; Jean François Dartigues
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422

8.  Using item banks to construct measures of patient reported outcomes in clinical trials: investigator perceptions.

Authors:  Kathryn E Flynn; Carrie B Dombeck; Esi Morgan DeWitt; Kevin A Schulman; Kevin P Weinfurt
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

9.  Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease.

Authors:  Margaret M Esiri; Steven A Chance
Journal:  Alzheimers Res Ther       Date:  2012-03-01       Impact factor: 6.982

10.  Improved utilization of ADAS-cog assessment data through item response theory based pharmacometric modeling.

Authors:  Sebastian Ueckert; Elodie L Plan; Kaori Ito; Mats O Karlsson; Brian Corrigan; Andrew C Hooker
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

View more
  4 in total

1.  Application of Item Response Theory to Model Disease Progression and Agomelatine Effect in Patients with Major Depressive Disorder.

Authors:  Marc Cerou; Sophie Peigné; Emmanuelle Comets; Marylore Chenel
Journal:  AAPS J       Date:  2019-11-12       Impact factor: 4.009

2.  Factors contributing to cognitive improvement effects of acupuncture in patients with mild cognitive impairment: a pilot randomized controlled trial.

Authors:  Jae-Hong Kim; Myoung-Rae Cho; Jeong-Cheol Shin; Gwang-Cheon Park; Jeong-Soon Lee
Journal:  Trials       Date:  2021-05-12       Impact factor: 2.279

3.  Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer's Disease Dementia via Lead-Lag Analysis.

Authors:  Manuel Fuentes; Arne Klostermann; Luca Kleineidam; Chris Bauer; Johannes Schuchhardt; Wolfgang Maier; Frank Jessen; Lutz Frölich; Jens Wiltfang; Johannes Kornhuber; Stefan Klöppel; Vera Schieting; Stefan J Teipel; Michael Wagner; Oliver Peters
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  Machine learning identifies novel markers predicting functional decline in older adults.

Authors:  Kate E Valerio; Sarah Prieto; Alexander N Hasselbach; Jena N Moody; Scott M Hayes; Jasmeet P Hayes
Journal:  Brain Commun       Date:  2021-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.